Mary Agnes Wilderotter
Mary Agnes Wilderotter's purchase track record
Mary Agnes Wilderotter has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/7/2022 | COST | $400K | +10.2% | +2.4% | -5.3% |
| 12/21/2021 | COST | $500K | +2.7% | -14.8% | -19.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Costco Faces Competition and Fed Impact Amid Sales Growth Outlook. Costco is navigating a mix of factors that could influence its near‑term performance. The latest Fed decision may tighten borrowing costs, while Aldi’s price cuts and Sam’s Club’s lower Halloween candy prices add competitive pressure. Strong sales growth in September could still support the company’s trajectory, but investors will watch how the retailer balances pricing and margin.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Fortinet Expands Cloud Security Framework Amid Sector Pullback. Fortinet announced an expansion of its global cybersecurity framework for hybrid and multi-cloud environments. This product update comes as cybersecurity stocks generally retreat from recent record highs due to market volatility. Mizuho recently raised its price target for the stock to $160 while maintaining an Underperform rating, reflecting mixed views on its valuation.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Sana Biotechnology Featured in Diabetes Treatment Analysis. Sana Biotechnology was the subject of a recent analysis titled 'A Shot At Diabetes,' which likely examines the company's potential in treating the condition. This coverage places the stock in the spotlight for investors watching biotech developments. The stock is currently trading near its support level, with an RSI indicating it may be oversold.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Lyft Faces $270M California Settlement and Lowered Price Target. Lyft agreed to pay over $270 million to settle California wage-theft claims, a significant financial obligation for the company. Additionally, Wells Fargo lowered its price target to $17, reflecting cautious sentiment. These developments occurred while broader industry issues, such as rising costs for gig workers, continue to shape the market landscape.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
HPE Stock Falls 20% Amid AI Financing Concerns. Hewlett Packard Enterprise shares dropped 20% this week, marking its worst weekly performance to date. The decline was driven by growing investor concerns regarding the financing of AI infrastructure, which triggered a broader selloff in hardware stocks like Dell and Super Micro. This sharp drop has pushed the stock toward its support levels, highlighting significant volatility in the AI sector.
Transaction History
| DOCU | ▼ Sell | Open Market | 1,000 | $69K | 10/1/2026 | View on chart |
| DOCU | ▼ Sell | Open Market | 1,096 | $77K | 9/16/2026 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 1,096 | $0 | 9/1/2026 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 729 | $0 | 5/29/2026 | View on chart |
| DOCU | ▼ Sell | Gift | 57,333 | $0 | 4/2/2026 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 3,000 | $53K | 4/1/2026 | View on chart |
| DOCU | ▼ Sell | Open Market | 3,000 | $144K | 4/1/2026 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 729 | $0 | 2/28/2026 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 729 | $0 | 11/29/2025 | View on chart |
| COST | ▲ Buy | Grant | 286 | $0 | 10/22/2025 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 729 | $0 | 8/29/2025 | View on chart |
| FTNT | ▲ Buy | Option Exercise | 1,130 | $0 | 6/12/2025 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 1,069 | $0 | 5/29/2025 | View on chart |
| FTNT | ▲ Buy | Option Exercise | 1,130 | $0 | 3/31/2025 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 1,068 | $0 | 2/28/2025 | View on chart |
| FTNT | ▲ Buy | Option Exercise | 1,130 | $0 | 12/31/2024 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 1,068 | $0 | 11/29/2024 | View on chart |
| COST | ▲ Buy | Grant | 303 | $0 | 10/22/2024 | View on chart |
| FTNT | ▲ Buy | Option Exercise | 1,129 | $0 | 9/30/2024 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 1,068 | $0 | 8/29/2024 | View on chart |
| FTNT | ▲ Buy | Option Exercise | 550 | $0 | 6/13/2024 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 998 | $0 | 5/29/2024 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 997 | $0 | 2/29/2024 | View on chart |
| COST | ▲ Buy | Grant | 19 | $0 | 1/12/2024 | View on chart |
| SANA | ▲ Buy | Grant | 1,470 | $0 | 1/5/2024 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 997 | $0 | 11/30/2023 | View on chart |
| COST | ▲ Buy | Grant | 489 | — | 10/22/2023 | View on chart |
| SANA | ▲ Buy | Grant | 2,077 | $0 | 10/5/2023 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 997 | $0 | 8/31/2023 | View on chart |
| LYFT | ▼ Sell | Open Market | 2,403 | $25K | 8/28/2023 | View on chart |
| SANA | ▲ Buy | Grant | 1,245 | $0 | 7/5/2023 | View on chart |
| LYFT | ▲ Buy | Grant | 24,645 | $0 | 6/15/2023 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 672 | $0 | 5/31/2023 | View on chart |
| DOCU | ▼ Sell | Tax Withholding | 62 | $0 | 5/31/2023 | View on chart |
| LYFT | ▼ Sell | Open Market | 1,827 | $15K | 5/26/2023 | View on chart |
| SANA | ▲ Buy | Grant | 2,314 | $0 | 4/5/2023 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 671 | $0 | 3/3/2023 | View on chart |
| DOCU | ▼ Sell | Tax Withholding | 81 | $0 | 3/3/2023 | View on chart |
| LYFT | ▼ Sell | Open Market | 1,826 | $19K | 2/27/2023 | View on chart |
| LYFT | ▼ Sell | Open Market | 1,826 | $30K | 2/1/2023 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 30,111 | $0 | 12/15/2022 | View on chart |
| DOCU | ▼ Sell | Tax Withholding | 10,300 | $613K | 12/15/2022 | View on chart |
| DOCU | ▼ Sell | Tax Withholding | 100 | $0 | 12/3/2022 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 671 | $0 | 12/3/2022 | View on chart |
| LYFT | ▼ Sell | Open Market | 1,826 | $20K | 11/28/2022 | View on chart |
| COST | ▲ Buy | Grant | 565 | — | 10/22/2022 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 671 | $0 | 9/3/2022 | View on chart |
| DOCU | ▼ Sell | Tax Withholding | 134 | $0 | 9/3/2022 | View on chart |
| LYFT | ▲ Buy | Grant | 18,732 | $0 | 6/16/2022 | View on chart |
| COST | ▲ Buy | Open Market | 850 | $400K | 6/7/2022 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 279 | $0 | 5/28/2022 | View on chart |
| LYFT | ▼ Sell | Open Market | 553 | $10K | 5/27/2022 | View on chart |
| HPE | ▲ Buy | Option Exercise | 14,479 | $0 | 4/5/2022 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 279 | $0 | 2/28/2022 | View on chart |
| LYFT | ▼ Sell | Open Market | 429 | $17K | 2/28/2022 | View on chart |
| LYFT | ▼ Sell | Open Market | 125 | $5K | 2/28/2022 | View on chart |
| COST | ▲ Buy | Open Market | 925 | $500K | 12/21/2021 | View on chart |
| LYFT | ▼ Sell | Open Market | 456 | $19K | 11/29/2021 | View on chart |
| LYFT | ▼ Sell | Open Market | 70 | $3K | 11/29/2021 | View on chart |
| LYFT | ▼ Sell | Open Market | 27 | $1K | 11/29/2021 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 279 | $0 | 11/28/2021 | View on chart |
| LYFT | ▼ Sell | Open Market | 114 | $6K | 11/12/2021 | View on chart |
| LYFT | ▼ Sell | Open Market | 2,746 | $145K | 11/12/2021 | View on chart |
| COST | ▲ Buy | Grant | 561 | — | 10/22/2021 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 278 | $0 | 8/28/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
DocuSign Quotation Resumes After Trading Halt
DocuSign shares resumed trading after a brief halt, marking the release of the security for quotation. This event coincides with broader positive momentum in the software sector, where peers like FactSet reported strong earnings and EPAM announced a significant share repurchase. Analysts currently hold an average price target of $69.99 for the stock.
DocuSign Quotation Resumes After Trading Halt. DocuSign shares resumed trading after a brief halt, marking the release of the security for quotation. This event coincides with broader positive momentum in the software sector, where peers like FactSet reported strong earnings and EPAM announced a significant share repurchase. Analysts currently hold an average price target of $69.99 for the stock.